Few developing countries will be interested, for example, in the
vaccine produced by Moderna Inc., which requires the sort of
super-cooled storage facilities they would struggle to build.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/there-will-be-a-price-to-pay-for-making-vaccines-too-expensive/articleshow/79381348.cms
No comments:
Post a Comment